NYSE:NHI - National Health Investors Stock Price, Price Target & More Sign in or create an account to add this stock to your watchlist. Get Started $74.26 -0.28 (-0.38 %) (As of 07/19/2018 08:00 AM ET)Previous Close$74.54Today's Range$73.57 - $74.5352-Week Range$62.71 - $81.60Volume119,200 shsAverage Volume180,124 shsMarket Capitalization$3.10 billionP/E Ratio13.80Dividend Yield5.37%Beta0.45 Company ProfileFinancialsAnalyst RatingsDividend HistoryEarnings HistoryInsider TradesHeadlinesOptions ChainSEC FilingsSocial MediaChart Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals. Visit www.nhireit.com for more information. Receive NHI News and Ratings via Email Sign-up to receive the latest news and ratings for NHI and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSE Industry Real estate investment trusts Sub-IndustrySpecialized REITs SectorFinance SymbolNYSE:NHI CUSIP63633D10 Webwww.nhireit.com Phone615-890-9100 Debt Debt-to-Equity Ratio0.88 Current Ratio15.21 Quick Ratio15.21 Price-To-Earnings Trailing P/E Ratio13.80 Forward P/E Ratio13.50 P/E Growth3.43 Sales & Book Value Annual Sales$278.66 million Price / Sales11.07 Cash Flow$5.5625 per share Price / Cash13.35 Book Value$31.83 per share Price / Book2.33 Profitability EPS (Most Recent Fiscal Year)$5.33 Net Income$159.36 million Net Margins53.88% Return on Equity11.69% Return on Assets6.06% Miscellaneous EmployeesN/A Outstanding Shares41,530,000Market Cap$3,095.81 National Health Investors (NYSE:NHI) Frequently Asked Questions What is National Health Investors' stock symbol? National Health Investors trades on the New York Stock Exchange (NYSE) under the ticker symbol "NHI." How often does National Health Investors pay dividends? What is the dividend yield for National Health Investors? National Health Investors declared a quarterly dividend on Tuesday, May 8th. Shareholders of record on Friday, June 29th will be given a dividend of $1.00 per share on Friday, August 10th. This represents a $4.00 dividend on an annualized basis and a yield of 5.39%. The ex-dividend date of this dividend is Thursday, June 28th. View National Health Investors' Dividend History. How were National Health Investors' earnings last quarter? National Health Investors Inc (NYSE:NHI) announced its earnings results on Tuesday, May, 8th. The real estate investment trust reported $0.92 earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of $1.34 by $0.42. The real estate investment trust had revenue of $72.75 million for the quarter, compared to the consensus estimate of $72.04 million. National Health Investors had a return on equity of 11.69% and a net margin of 53.88%. The business's revenue was up 9.6% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.25 earnings per share. View National Health Investors' Earnings History. When is National Health Investors' next earnings date? National Health Investors is scheduled to release their next quarterly earnings announcement on Tuesday, August, 7th 2018. View Earnings Estimates for National Health Investors. What guidance has National Health Investors issued on next quarter's earnings? National Health Investors issued an update on its FY18 earnings guidance on Tuesday, May, 8th. The company provided earnings per share (EPS) guidance of $5.45-$5.51 for the period, compared to the Thomson Reuters consensus estimate of $5.50. What price target have analysts set for NHI? 10 equities research analysts have issued twelve-month target prices for National Health Investors' stock. Their forecasts range from $60.00 to $79.00. On average, they anticipate National Health Investors' share price to reach $71.8750 in the next year. This suggests that the stock has a possible downside of 3.2%. View Analyst Ratings for National Health Investors. What is the consensus analysts' recommendation for National Health Investors? 10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for National Health Investors in the last year. There are currently 1 sell rating, 5 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold." What are Wall Street analysts saying about National Health Investors stock? Here are some recent quotes from research analysts about National Health Investors stock: 1. Cantor Fitzgerald analysts commented, "1Q18 results were slightly below our estimates, but in-line with FactSet consensus. Normalized FFO was $1.35 (vs. our $1.37 estimate and $1.34 consensus), and nAFFO was $1.22 (vs. our $1.25 estimate, $1.23 consensus). NHI affirmed its full year nFFO ($5.45-$5.51) and nAFFO ($4.99-$5.03) guidance." (5/8/2018) 2. According to Zacks Investment Research, "National Health Investors, Inc. is a real estate investment trust which invests in income producing health care properties primarily in the long-term care industry. The company provides current income for distribution to stockholders through investments in health care related facilities, including long-term care facilities, acute care hospitals, medical office buildings, retirement centers and assisted living facilities. " (11/17/2017) Who are some of National Health Investors' key competitors? Some companies that are related to National Health Investors include ANNALY Cap Mgmt/SH (NLY), HCP (HCP), Extra Space Storage (EXR), Klépierre (KLPEF), Mid-America Apartment Communities (MAA), SINO Ld Ltd/S (SNLAY), Regency Centers (REG), Duke Realty (DRE), Iron Mountain (IRM), UDR (UDR), Federal Realty Investment Trust (FRT), SL Green Realty (SLG), Camden Property Trust (CPT), Equity Lifestyle Properties (ELS) and AGNC Investment (AGNC). Who are National Health Investors' key executives? National Health Investors' management team includes the folowing people: Mr. D. Eric Mendelsohn, Pres & CEO (Age 56)Mr. John L. Spaid, Exec. VP of Fin. (Age 58)Mr. Kevin Carlton Pascoe, Chief Investment Officer (Age 37)Mr. Roger R. Hopkins, Chief Accounting Officer (Age 56)Ms. Colleen Schaller, Director of Investor Relations Has National Health Investors been receiving favorable news coverage? Media headlines about NHI stock have trended somewhat positive this week, Accern reports. The research firm rates the sentiment of press coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. National Health Investors earned a coverage optimism score of 0.10 on Accern's scale. They also gave news coverage about the real estate investment trust an impact score of 45.96 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company's share price in the near future. Who are National Health Investors' major shareholders? National Health Investors' stock is owned by a variety of of retail and institutional investors. Top institutional investors include Hamlin Capital Management LLC (1.51%), State of Alaska Department of Revenue (0.03%), Xact Kapitalforvaltning AB (0.01%) and Campbell & CO Investment Adviser LLC (0.01%). Company insiders that own National Health Investors stock include D Eric Mendelsohn, John L Spaid, Kevin Carlton Pascoe and Robert A Mccabe Jr. View Institutional Ownership Trends for National Health Investors. Which institutional investors are selling National Health Investors stock? NHI stock was sold by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue. View Insider Buying and Selling for National Health Investors. Which institutional investors are buying National Health Investors stock? NHI stock was bought by a variety of institutional investors in the last quarter, including Hamlin Capital Management LLC, Xact Kapitalforvaltning AB and Campbell & CO Investment Adviser LLC. Company insiders that have bought National Health Investors stock in the last two years include D Eric Mendelsohn, John L Spaid and Robert A Mccabe Jr. View Insider Buying and Selling for National Health Investors. How do I buy shares of National Health Investors? Shares of NHI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is National Health Investors' stock price today? One share of NHI stock can currently be purchased for approximately $74.26. How big of a company is National Health Investors? National Health Investors has a market capitalization of $3.10 billion and generates $278.66 million in revenue each year. The real estate investment trust earns $159.36 million in net income (profit) each year or $5.33 on an earnings per share basis. How can I contact National Health Investors? National Health Investors' mailing address is 222 ROBERT ROSE DRIVE, MURFREESBORO TN, 37129. The real estate investment trust can be reached via phone at 615-890-9100 or via email at [email protected] MarketBeat Community Rating for National Health Investors (NYSE NHI)Community Ranking: 2.2 out of 5 ( )Outperform Votes: 227 (Vote Outperform)Underperform Votes: 288 (Vote Underperform)Total Votes: 515MarketBeat's community ratings are surveys of what our community members think about National Health Investors and other stocks. Vote "Outperform" if you believe NHI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NHI will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 7/19/2018 by MarketBeat.com StaffFeatured Article: Are Wall Street analysts' stock ratings worth following?